Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CollPlant Biotechnologies (CLGN) Shares Outstanding (Weighted Average) (2017 - 2025)

CollPlant Biotechnologies filings provide 9 years of Shares Outstanding (Weighted Average) readings, the most recent being $12.2 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 6.54% to $12.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.2 million, a 6.54% increase, with the full-year FY2025 number at $12.2 million, up 6.54% from a year prior.
  • Shares Outstanding (Weighted Average) hit $12.2 million in Q4 2025 for CollPlant Biotechnologies, up from $11.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $8.4 billion in Q1 2021 to a low of $250000.0 in Q1 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $11.4 million (2023), compared with a mean of $1.2 billion.
  • The widest YoY moves for Shares Outstanding (Weighted Average): up 2351.85% in 2022, down 100.0% in 2022.
  • CollPlant Biotechnologies' Shares Outstanding (Weighted Average) stood at $450000.0 in 2021, then soared by 2351.85% to $11.0 million in 2022, then increased by 3.23% to $11.4 million in 2023, then increased by 0.57% to $11.5 million in 2024, then rose by 6.54% to $12.2 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $12.2 million (Q4 2025), $11.5 million (Q4 2024), and $11.4 million (Q4 2023) per Business Quant data.